Diagnostic Criteria for Functional Hypothalamic Amenorrhea

Hormonal Profile

• The American College of Obstetricians and Gynecologists notes that low-normal LH and FSH levels, such as LH 4.8 IU/L and FSH 4.7 IU/L, are characteristic of Functional Hypothalamic Amenorrhea (FHA) 1, 2
• The Endocrine Society recommends that an LH:FSH ratio of approximately 1.0, as seen in this patient, effectively rules out Polycystic Ovary Syndrome (PCOS) 3, 4
• FHA is characterized by functional reduction in GnRH pulsatile secretion leading to decreased LH pulses and reduced serum LH and FSH levels, according to the Human Reproduction Update 1, 2

Estrogen Status

• The American College of Obstetricians and Gynecologists states that a low oestradiol level, such as 69 pmol/L, indicates hypoestrogenism, which is consistent with FHA 5, 6
• The Endocrine Society notes that direct oestradiol assays are insensitive below 20 pg/ml, and this patient's level is just at that threshold 5, 6

Androgen Profile

• The American College of Obstetricians and Gynecologists recommends that a normal-to-low total testosterone level, such as 0.5 nmol/L, and a very low Free Androgen Index, such as 0.4%, exclude hyperandrogenism and support a diagnosis of FHA 2, 7
• The Human Reproduction Update states that FHA patients have higher Sex Hormone-Binding Globulin (SHBG) levels than PCOS patients, which is characteristic of FHA rather than PCOS 2, 5, 7

Metabolic Parameters

• The American Diabetes Association notes that a normal HbA1c level, such as 36 mmol/mol, indicates normal insulin sensitivity, which is typical of FHA patients 5, 8
• The Endocrine Society states that FHA patients typically have low insulin levels and normal insulin sensitivity, contrasting with PCOS where insulin resistance is common 5, 8

Clinical Context

• The American College of Obstetricians and Gynecologists notes that heavy fasting and calorie restriction are classic precipitants of FHA, and this patient's history is consistent with this diagnosis 1, 2, 3
• The Human Reproduction Update recommends that the temporal relationship between caloric restriction and amenorrhea onset is diagnostic of FHA 1, 8

Diagnostic Pitfalls

• The American College of Obstetricians and Gynecologists warns that if a patient has polycystic ovarian morphology (PCOM) on ultrasound, they should not be misdiagnosed with PCOS, and instead, FHA-PCOM should be considered 2, 8, 3
• The Endocrine Society states that the key differentiators between FHA-PCOM and PCOS are a clear history of energy deficit/caloric restriction, low-normal LH and FSH, very high SHBG, and low androgens with a very low Free Androgen Index 2, 8, 7

Immediate Clinical Implications

• The American College of Obstetricians and Gynecologists recommends that patients with FHA require urgent attention to bone health due to hypoestrogenism, and low estradiol levels put them at significant risk for decreased bone mineral density and osteoporosis 3, 4, 9

Diagnostic Criteria for Functional Hypothalamic Amenorrhea (FHA)

Key Features That Would Rule Out FHA

• Elevated LH:FSH ratio exceeding 2.0 strongly suggests PCOS rather than FHA, as approximately 82% of FHA patients have an LH:FSH ratio <1 10, 11
• Elevated gonadotropins (FSH and LH) would indicate primary ovarian insufficiency rather than hypothalamic suppression 12
• Normal or elevated estradiol levels would contradict the hypoestrogenism characteristic of FHA 13
• Positive progestin challenge test suggests adequate estrogen exposure, though this is not absolute since up to 60% of FHA patients may still have withdrawal bleeding 14, 10, 11

Metabolic and Androgen Markers

• Evidence of insulin resistance with elevated fasting insulin or abnormal glucose tolerance would favor PCOS over FHA, as FHA patients typically demonstrate low insulin levels and normal insulin sensitivity 14, 10
• Frank hyperandrogenism with significantly elevated total testosterone and elevated Free Androgen Index would suggest PCOS rather than FHA 15
• Low SHBG levels are more characteristic of PCOS than FHA; FHA patients typically have higher SHBG levels compared to PCOS patients 14, 12, 10

Clinical Context That Contradicts FHA

• Absence of typical FHA triggers including no history of excessive exercise, no caloric restriction or energy deficit, no significant weight loss, and no psychological stress would make FHA diagnosis questionable 10, 11
• High or normal BMI with metabolic syndrome features would favor PCOS, as FHA patients typically present with low or normal BMI and lean body habitus 15
• Thick endometrial stripe on ultrasound indicating adequate estrogen stimulation would contradict the estrogen deficiency expected in FHA 14, 10, 11

The FHA-PCOM Diagnostic Pitfall

• 41.9-46.7% of women with FHA have polycystic ovarian morphology (PCOM), which can lead to misdiagnosis as PCOS 12, 15
• FHA-PCOM patients still demonstrate the core features of FHA: low gonadotropins, hypoestrogenism, clear history of energy deficit or stress, and high SHBG 12, 15

Critical Differentiators Between FHA-PCOM and PCOS Phenotype D

• LH:FSH ratio: Ratio <1 in 82% of FHA cases versus ratio >2 in PCOS 10, 11
• SHBG levels: Higher in FHA-PCOM than in PCOS, reflecting different metabolic profiles 14, 12, 10
• Endometrial thickness: Thin endometrium with clear signs of estrogen deficiency supports FHA 14, 10, 11

Important Clinical Caveats

• No single parameter is absolutely reliable for distinguishing FHA from PCOS, particularly in the FHA-PCOM subgroup; clinical judgment must integrate multiple factors 14, 10, 11
• The progestin challenge test has limited utility given that up to 60% of FHA patients may have withdrawal bleeding, and endometrial thickness is a better indicator 14, 10, 11

Gonadotropin Suppression in Functional Hypothalamic Amenorrhea

Introduction to FHA

• LH and FSH can be completely flatlined (undetectable or <2 IU/L) in severe cases of Functional Hypothalamic Amenorrhea, though the more typical presentation is "low-normal" levels, according to the American Society for Reproductive Medicine 16

Diagnostic Criteria

• In some studies defining FHA with strict criteria, patients had to have both LH and FSH <2 IU/L to distinguish them from other conditions, demonstrating that this degree of suppression is recognized in the literature, with a strength of evidence based on clinical studies 16

Diagnostic Implications

• LH and FSH both <2 IU/L with estradiol <100 pmol/L strongly indicates hypothalamic hypogonadism/severe FHA rather than PCOS or other conditions, as stated by the Endocrine Society 16